Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 46.07 | (478.69) | (705.93)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-26 | 110.32 | (479.31) | (675.64)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 252.00 | (400.42) | (544.01)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Agios Pharmaceuticals to sell cancer portfolio t... | 21-Dec-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 29.17 |
| Change Today | $ 4.58 |
| % Change | 18.63 % |
| 52 Week High | $45.49 |
| 52 Week Low | $22.34 |
| Volume | 6,310,491 |
| Shares Issued | 58.68m |
| Market Cap | $1,711.72m |
| RiskGrade | 304 |
| Strong Buy | 3 |
| Buy | 4 |
| Neutral | 2 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 10 |

You are here: research